Dr. Levy on the Safety Profile, Dosing of Cabozantinib in HCCByAnna T. Levy, DOApril 9th 2021Anna T. Levy, DO, discuses the safety profile and appropriate dosing of cabozantinib in patients with hepatocellular carcinoma.
Dr. Levy on Future Research Directions for Lenvatinib in HCCByAnna T. Levy, DOMarch 4th 2021Anna T. Levy, DO, discuses future research directions for lenvatinib in patients with hepatocellular carcinoma.